Aurora Cannabis Inc.
Aurora Cannabis Inc. (ACB.TO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
acb.to · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Hold
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $4.78
Short-Term Price Prediction
Short-term predictions are paused during the ±3-day earnings window to avoid unreliable signals.
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -50.0% |
| 2028 | $2 | -62.5% |
| 2029 | $2 | -67.2% |
| 2030 | $1 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ACB.TO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2020-12-17 | BMO Capital | Downgrade ↓ | Market Perform→Underperform |
| 2020-11-25 | Piper Sandler | Downgrade ↓ | Neutral→Underweight |
| 2020-11-25 | Piper Sandler | Maintains | Neutral→Neutral |
| 2020-11-25 | Piper Sandler | Upgrade ↑ | Underweight→Neutral |
| 2020-11-25 | Ladenburg Thalmann | Downgrade ↓ | Buy→Neutral |
| 2020-11-25 | B of A Securities | Downgrade ↓ | Buy→Neutral |
| 2020-11-25 | Piper Jaffray | Maintains | Neutral→Neutral |
| 2020-11-25 | Stifel | Downgrade ↓ | Hold→Sell |
| 2020-11-25 | Bank of America | Downgrade ↓ | Buy→Neutral |
| 2020-09-22 | Piper Sandler | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Aurora Cannabis Inc. (ACB.TO) stock. Of the recent 19 rating actions, 2 were upgrades and 12 were downgrades. 7 analysts currently cover ACB.TO.
Analyst Recommendation Trends
ACB.TO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$358M
↓ 2.7% YoY
Revenue Next Year
$326M
↓ 9.0% YoY
EPS This Year
$-1.20
EPS Next Year
$0.19
↓ 116.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ACB.TO EPS of $-1.20 for the current fiscal year, based on estimates from 4 analysts. The ACB.TO revenue forecast is $358M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ACB.TO stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ACB.TO price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The ACB.TO stock price prediction for 2027 estimates an average of $2. The ACB.TO stock prediction for 2030 projects a range of $1–$2.
Aurora Cannabis Inc. trades on TSX under the ticker ACB.TO. The ACB.TO stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
ACB.TO forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month ACB.TO price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $4.78.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.